{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:35:07Z","timestamp":1784039707763,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1245\/s10434-024-16843-z","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:08:58Z","timestamp":1737047338000},"page":"2323-2328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Landmark Series: Testing in Thyroid Nodule Fine Needle Aspiration Cytology"],"prefix":"10.1245","volume":"32","author":[{"given":"Kimberly M.","family":"Ramonell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwah","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"11","key":"16843_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1089\/thy.2009.0274","volume":"19","author":"ES Cibas","year":"2009","unstructured":"Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159\u201365.","journal-title":"Thyroid"},{"issue":"11","key":"16843_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2017.0500","volume":"27","author":"ES Cibas","year":"2017","unstructured":"Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341\u20136.","journal-title":"Thyroid"},{"issue":"9","key":"16843_CR3","first-page":"1039","volume":"33","author":"SZ Ali","year":"2023","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid. 2023;33(9):1039\u201344.","journal-title":"Thyroid"},{"issue":"4","key":"16843_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000339959","volume":"56","author":"M Bongiovanni","year":"2012","unstructured":"Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol. 2012;56(4):333\u20139.","journal-title":"Acta Cytol"},{"issue":"11","key":"16843_CR5","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1245\/s10434-014-3743-1","volume":"21","author":"CM Kiernan","year":"2014","unstructured":"Kiernan CM, Broome JT, Solorzano CC. The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years. Ann Surg Oncol. 2014;21(11):3522\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"16843_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.surg.2022.06.061","volume":"173","author":"KM Ramonell","year":"2023","unstructured":"Ramonell KM, Ohori NP, Liu JB, et al. Changes in thyroid nodule cytology rates after institutional implementation of the Thyroid Imaging Reporting and Data System. Surgery. 2023;173(1):232\u20138.","journal-title":"Surgery"},{"issue":"1","key":"16843_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5858\/arpa.2014-0056-RA","volume":"139","author":"H Liu","year":"2015","unstructured":"Liu H, Lin F. Application of immunohistochemistry in thyroid pathology. Arch Pathol Lab Med. 2015;139(1):67\u201382.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"16843_CR8","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1210\/jc.2009-0247","volume":"94","author":"YE Nikiforov","year":"2009","unstructured":"Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94(6):2092\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"16843_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1056\/NEJMoa1203208","volume":"367","author":"EK Alexander","year":"2012","unstructured":"Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705\u201315.","journal-title":"N Engl J Med"},{"key":"16843_CR10","unstructured":"ThyroSeq. <https:\/\/www.thyroseq.com\/physicians\/educational-resources\/publications\/>. Accessed 11\/07\/2024."},{"key":"16843_CR11","unstructured":"Afirma <https:\/\/www.afirma.com\/latest-news-and-evidence\/afirma-clinical-experience\/>. Accessed 11\/07\/2024."},{"key":"16843_CR12","unstructured":"ThygeNEXT\/ThyraMIR. <https:\/\/thygenext-thyramir.com\/evidence\/>. Accessed 11\/07\/2024."},{"issue":"9","key":"16843_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamasurg.2018.1153","volume":"153","author":"KN Patel","year":"2018","unstructured":"Patel KN, Angell TE, Babiarz J, et al. Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules. JAMA Surg. 2018;153(9):817\u201324.","journal-title":"JAMA Surg"},{"issue":"12","key":"16843_CR14","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/dc.24564","volume":"48","author":"MA Lupo","year":"2020","unstructured":"Lupo MA, Walts AE, Sistrunk JW, et al. Multiplatform molecular test performance in indeterminate thyroid nodules. Diagn Cytopathol. 2020;48(12):1254\u201364.","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"16843_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","volume":"5","author":"DL Steward","year":"2019","unstructured":"Steward DL, Carty SE, Sippel RS, et al. Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study. JAMA Oncol. 2019;5(2):204\u201312.","journal-title":"JAMA Oncol"},{"issue":"1","key":"16843_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamaoncol.2020.5935","volume":"7","author":"MJ Livhits","year":"2021","unstructured":"Livhits MJ, Zhu CY, Kuo EJ, et al. Effectiveness of molecular testing techniques for diagnosis of indeterminate thyroid nodules: a randomized clinical trial. JAMA Oncol. 2021;7(1):70\u20137.","journal-title":"JAMA Oncol"},{"issue":"10","key":"16843_CR17","first-page":"1144","volume":"32","author":"C DiGennaro","year":"2022","unstructured":"DiGennaro C, Vahdatzad V, Jalali MS, et al. Assessing bias and limitations of clinical validation studies of molecular diagnostic tests for indeterminate thyroid nodules: systematic review and meta-analysis. Thyroid. 2022;32(10):1144\u201357.","journal-title":"Thyroid"},{"issue":"9","key":"16843_CR18","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1210\/clinem\/dgad181","volume":"108","author":"NE Kim","year":"2023","unstructured":"Kim NE, Raghunathan RS, Hughes EG, et al. Bethesda III and IV thyroid nodules managed nonoperatively after molecular testing with Afirma GSC or Thyroseq v3. J Clin Endocrinol Metab. 2023;108(9):e698\u2013703.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"16843_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"3","key":"16843_CR20","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/SLA.0000000000003580","volume":"271","author":"KN Patel","year":"2020","unstructured":"Patel KN, Yip L, Lubitz CC, et al. The American association of endocrine surgeons guidelines for the definitive surgical management of thyroid disease in adults. Ann Surg. 2020;271(3):e21\u201393.","journal-title":"Ann Surg"},{"issue":"1","key":"16843_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.surg.2017.10.004","volume":"163","author":"CJ Balentine","year":"2018","unstructured":"Balentine CJ, Vanness DJ, Schneider DF. Cost-effectiveness of lobectomy versus genetic testing (Afirma(R)) for indeterminate thyroid nodules: considering the costs of surveillance. Surgery. 2018;163(1):88\u201396.","journal-title":"Surgery"},{"issue":"9","key":"16843_CR22","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1089\/thy.2018.0779","volume":"29","author":"KJ Nicholson","year":"2019","unstructured":"Nicholson KJ, Roberts MS, McCoy KL, Carty SE, Yip L. Molecular testing versus diagnostic lobectomy in Bethesda III\/IV thyroid nodules: a cost-effectiveness analysis. Thyroid. 2019;29(9):1237\u201343.","journal-title":"Thyroid"},{"issue":"12","key":"16843_CR23","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1089\/thy.2022.0282","volume":"32","author":"JM Skaugen","year":"2022","unstructured":"Skaugen JM, Taneja C, Liu JB, et al. Performance of a multigene genomic classifier in thyroid nodules with suspicious for malignancy cytology. Thyroid. 2022;32(12):1500\u20138.","journal-title":"Thyroid"},{"issue":"8","key":"16843_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaoto.2023.1494","volume":"149","author":"MA Schumm","year":"2023","unstructured":"Schumm MA, Shu ML, Hughes EG, et al. Prognostic value of preoperative molecular testing and implications for initial surgical management in thyroid nodules harboring suspected (Bethesda V) or known (Bethesda VI) papillary thyroid cancer. JAMA Otolaryngol Head Neck Surg. 2023;149(8):735\u201342.","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16843-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16843-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16843-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:27:29Z","timestamp":1741195649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16843-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["16843"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16843-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Disclosures: Dr. Ramonell is\nan employee of University of Pittsburgh Physicians which\nis an affiliate of UPMC. UPMC has granted CBLPath, Inc license to market the\nThyroSeq trademark for commercial use. Dr. Ramonell receive d no related direct or\nindirect compensation for ThyroSeq . No other disclosur es are reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}